Showing 653 results
- Media Release /Acromegaly, an endocrine disorder resulting from elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels, is associated with high mortality(1,2)Phase III data show patients on…
- Media Release /
- Media Release /-- Number one ranking acknowledges Novartis Pharmaceuticals Corporation's commitment to and leadership in diversity and inclusion-- Reflects a decade of effort to embed diversity and inclusion into…
- Media Release /
- Media Release /- FEATURE and JUNCTURE data show secukinumab delivered significant skin clearance at week 12(1,2)- Patients reported high satisfaction with self-administration of secukinumab pre-filled syringe or…
- Media Release /
- Media Release /- First-in-class medicine approved for CIU, a burdensome skin condition that can cause hives, severe itch, and swelling that can last many months and years- Xolair® is approved for CIU patients age…
- Media Release /
- Media Release /Patient safety and well-being are highest priority at Novartis Pharmaceuticals Corporation (NPC) Patient adherence activities provide important education and support to help patients…
- Media Release /
Pagination
- ‹ Previous page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- …
- 66
- › Next page